Doxorubicin and interferon: rationale and clinical experience

Cancer Treat Rev. 1985 Dec:12 Suppl B:61-7.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Doxorubicin / administration & dosage*
  • Humans
  • Interferon Type I / administration & dosage*
  • Neoplasms / therapy*
  • Recombinant Proteins / administration & dosage

Substances

  • Interferon Type I
  • Recombinant Proteins
  • Doxorubicin